An official website of the United States government
NIH Guide: Weekly Index for January 19, 2024
Weekly NIH Guide Notices
January 19, 2024
General Notices
-
NIGMS Support to Utilize Data and Biospecimens Generated by the ARDS, Pneumonia, and Sepsis Phenotyping (APS) Consortium
(NOT-GM-24-018)National Institute of General Medical Sciences
-
Notice of Information of Intent to Publish Research Opportunity Announcements for the NeuroNEXT Clinical Trials: Stage 1 (Preliminary) and Stage 2 (Protocol) Applications (OT2)
(NOT-NS-24-045)National Institute of Neurological Disorders and Stroke
-
Notice of Pre-Application Webinar for Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
(NOT-RM-24-004)Office of Strategic Coordination (Common Fund)
Notice of Changes to Funding Opportunities
-
Notice of Need to Expire and Reissue NOT-AT-21-014 "Notice of Special Interest: NCCIH T32 Complementary and Integrative Health Practitioner Supplement Program for Pre- and Postdoctoral Candidates" to Change Due Dates
(NOT-AT-24-030)National Center for Complementary and Integrative Health
-
Notice of NIDCD Participation in PAR-23-298 Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
(NOT-DC-24-018)National Institute on Deafness and Other Communication Disorders
-
Notice of Clarification to NIEHS' Participation in PA-23-230 "PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)"
(NOT-ES-24-006)National Institute of Environmental Health Sciences
-
Notice of Participation of the NIMHD in PAR-24-080, "Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)"
(NOT-MD-24-005)National Institute on Minority Health and Health Disparities
-
Notice of Extension to PAR-21-130, PAR-21-131, PAR-21-132, PAR-21-133, PAR-21-134, PAR-21-135, PAR-21-136 and PAR-21-137
(NOT-MH-24-155)National Institute of Mental Health
-
RESCINDED - Notice of Change: Extension of PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)"
(NOT-NS-24-038)National Institute of Neurological Disorders and Stroke
-
Notice of Change: Extension of PAR-21-327 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)"
(NOT-NS-24-040)National Institute of Neurological Disorders and Stroke
-
Notice of Change: Extension of PAR-21-328 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)"
(NOT-NS-24-041)National Institute of Neurological Disorders and Stroke
-
Notice of Change: Extension of PAR-21-122, PAR-21-123, PAR-21-124 Innovation Grants to Nurture Initial Translational Efforts (IGNITE) NOFOs by One Additional Council Round
(NOT-NS-24-048)National Institute of Neurological Disorders and Stroke
Notices of Special Interest
-
Notice of Special Interest (NOSI): Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome Across the Lifespan (R21 Clinical Trial Not Allowed)
(NOT-OD-24-044)Office of the Director, NIHNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human Development
Funding Opportunities
-
International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)
(PAR-24-114)John E. Fogarty International CenterNational Cancer InstituteNational Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): March 9, 2026
-
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
(PAR-24-122)National Cancer InstituteApplication Receipt Date(s): November 5, 2024
-
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
(RFA-DA-25-060)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Clinical Sites for the Environmental influences on Child Health Outcomes (ECHO) IDeA States Pediatric Clinical Trials Network - 3 (UG1 Clinical Trial Required)
(RFA-OD-24-008)Office of the Director, NIHNational Institute of General Medical SciencesNational Institute on Drug AbuseEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentOffice of Nutrition ResearchOffice of Dietary SupplementsOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): April 15, 2024
-
Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network - 3 (U24 Clinical Trial RequiredInfrastructure)
(RFA-OD-24-009)Office of the Director, NIHNational Institute of General Medical SciencesNational Institute on Drug AbuseEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentOffice of Nutrition ResearchOffice of Dietary SupplementsOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): April 15, 2024
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster